精品资料
Carbamazepine Tablets with a History of Clinical Failures,”Pharmaceutical Research, 9:1612-1616.
4.Moore, J. W. and H. H. Flanner, 1996,“Mathematical Comparison of Dissolution Profiles,”Pharmaceutical Technology, 20 (6):64-74.
5.Shah, V. P., et al., 1989, “In Vitro Dissolution Profile of Water Insoluble Drug Dosage Forms inthe Presence of Surfactants,”Pharmaceutical Research, 6:612-618.
6.Shah, V. P., et al., 1992,“Influence of Higher Rate ofAgitation on Release Patterns of Immediate Release Drug Products,”Journal of Pharmaceutical Science, 81:500-503.
7.Shah, V. P., J. P. Skelly, W. H. Barr, H. Malinowski, and G. L. Amidon, 1992,“Scale-up of Controlled Release Products –
PreliminaryConsiderations,”Pharmaceutical Technology, 16(5):35-40.
8.Shah, V. P., et al., 1995,“In Vivo Dissolution of Sparingly Water Soluble Drug Dosage Forms,” International Journal of Pharmaceutics, 125:99-106.
9.Siewert, M., 1995,“FIP Guidelines for Dissolution Testing of Solid Oral Products,”Pharm.Ind. 57:362-369.
10. Skelly, J. P., G. L. Amidon, W. H. Barr, L. Z. Benet, J. E. Carter, J. R. Robinson, V. P. Shah, and A. Yacobi, 1990,“In Vitro and
仅供学习与交流，如有侵权请联系网站删除 谢谢21
精品资料
In Vivo Testing and Correlation for Oral Controlled/Modified-Release Dosage Forms,”Pharmaceutical Research, 7:975-982.
11. 国家食品药品监督管理局，已上市化学药品变更研究的技术指导原则（一），2008.
12.中国药典2010版二部附录，溶出度测定法。
13. British Pharmacopeia 2012，Dissolution test for tablets and capsules.
仅供学习与交流，如有侵权请联系网站删除 谢谢22
精品资料
仅供学习与交流，如有侵权请联系网站删除 谢谢23
溶出度指导原则教案资料
